Skip to main navigation Skip to search Skip to main content

Therapeutic effects of shibashin misena® against fine-dust-induced pulmonary disorders in mice

  • Zhenglin Piao
  • , Jae Kuk Yoo
  • , Byeong Wook Park
  • , Seung Bo Seo
  • , Sung Jin Park
  • , Ha Young Jeon
  • , Md Mahbubur Rahman
  • , Namsoo Kim
  • , Sokho Kim*
  • *Corresponding author for this work
  • Jeonbuk National University
  • HAN KOOK SHIN YAK PHARMACEUTICAL CO., LTD. Nonsan
  • Knotus Co., Ltd.
  • Chungbuk National University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Introduction: In recent decades, fine-dust particulate matter (FM) has become a potential health hazard, causing various pathological respiratory disorders around the world. Inflammation induced by FM is regarded as a major cause of respiratory disorder in humans. The purpose of this study was to evaluate the therapeutic efficacy of Shibashin Misena®, a functional food composed of various bioactive ingredients, on FM-induced respiratory disorders in mice. Materials and methods: Briefly, 40 mice were divided equally into four groups: normal controls (NC); FM-induced control group (FC); FM group treated with Shibashin Misena® 0.1 mL/head/day (FM0.1); FM group treated with Shibashin Misena® 0.2 mL/head/day (FM0.2). Results: FM significantly induced TNF-α, IL-17A, IL-1β, and TGF-β in bronchoalveolar lavage fluid (BALF) collected from the FM mice. Compared with FC, Shibashin Misena® decreased TNF-α, IL-17A, and IL-1β levels in BALF, and histopathologic evaluations revealed that Shibashin Misena® treatment significantly reduced inflammatory-cell infiltration and fibrosis related collagen deposition in lung tissue. Conclusion: This study demonstrated that Shibashin Misena® decreased FM-induced inflammation and fibrosis in lung tissue. Thus, Shibashin Misena® could be an effective supplement to prevent or improve FM-induced pulmonary disorders.

Original languageEnglish
Article number110018
JournalBiomedicine and Pharmacotherapy
Volume125
DOIs
StatePublished - 2020.05

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Fibrosis
  • Fine-dust particulate matter
  • Inflammation
  • Pulmonary disorders
  • Shibashin misena®

Quacquarelli Symonds(QS) Subject Topics

  • Pharmacy & Pharmacology

Fingerprint

Dive into the research topics of 'Therapeutic effects of shibashin misena® against fine-dust-induced pulmonary disorders in mice'. Together they form a unique fingerprint.

Cite this